How cells respond to myriad stimuli with finite signaling machinery is central to immunology. In naive T cells, the inherent effect of ligand strength on activation pathways and endpoints has remained controversial, confounded by environmental fluctuations and intercellular variability within populations. Here we studied how ligand potency affected the activation of CD8 + T cells in vitro, through the use of genome-wide RNA, multi-dimensional protein and functional measurements in single cells. Our data revealed that strong ligands drove more efficient and uniform activation than did weak ligands, but all activated cells were fully cytolytic. Notably, activation followed the same transcriptional pathways regardless of ligand potency. Thus, stimulation strength did not intrinsically dictate the T cell-activation route or phenotype; instead, it controlled how rapidly and simultaneously the cells initiated activation, allowing limited machinery to elicit wide-ranging responses.
C ytotoxic T lymphocytes (CTLs) are critical for immunological defense against tumors and viral pathogens. These programmed killer cells develop from naive CD8 + T cells over a multi-day activation process that depends on the activating stimulus as well as the surrounding immunological environment. T cell activation begins when the T cell antigen receptor (TCR) on a naive CD8 + T cell recognizes a complex of peptide-major histocompatibility complex class I (pMHC) on an antigen-presenting cell (APC) 1, 2 . If the TCR-pMHC interaction is strong enough to overcome the negative feedback loops that control basal T cell signaling, additional signaling components are recruited to the plasma membrane. This initiates multiple coordinated enzymatic cascades that regulate integrin affinity, cytoskeletal rearrangements, metabolic changes and transcription-factor activity, which are essential for the proliferation and effector differentiation of T cells.
Altering the affinity of the TCR-pMHC interaction can affect immunological outcomes in both thymic selection and T cell activation in the periphery 3, 4 . In thymocytes, TCR-pMHC affinity determines whether cells undergo positive selection or negative selection [5] [6] [7] . In the periphery, various studies have found T cell responses to be graded or 'thresholded' in terms of ligand affinity, with stronger ligands generally inducing a larger T cell response [8] [9] [10] [11] [12] [13] . In vitro studies have shown that reducing ligand affinity can decrease the molecular 'readouts' of naive CD8 + T cell activation, including calcium flux, kinase and transcription-factor activity, surface expression of receptors and cytokines, and proliferation 5, 11, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Similarly, changing the ligand concentration or co-stimulatory signals can affect T cell activation 11, 16, 21, [24] [25] [26] [27] [28] . However, T cell-activation assays differ between studies, and changes in T cell responses to altered ligand affinity are reported to be analog in some studies and digital in others 3, 4, 17, 18, 21, 23, 27, 29, 30 . Additionally, reports conflict over whether ligand potency controls response magnitude 13, 15, 16, 20 , speed 19 or frequency 17, 18 or a combination thereof 21, 22, 30 . A substantial challenge in investigating early T cell activation is that populations of identically stimulated T cells exhibit extensive heterogeneity. Previous studies have been limited in the number of markers that could be assessed in individual cells or required pooled populations for genome-wide measurements. Thus, it has been difficult to identify the intrinsic mechanism by which ligand potency affects the integrated organization of gene-expression changes within an individual cell. Singlecell technologies now allow the investigation of individual cells at a molecular level in an unbiased, genome-wide manner, which has enabled researchers to address this question.
Here we used five single-cell methods to measure the genomewide transcriptomes and targeted proteomic and functional profiles of naive CD8 + T cells activated in a controlled in vitro environment with peptide ligands of various potencies. We found that reducing ligand potency decreased the rate at which single T cells initiated transcriptional activation, which drove increased heterogeneity of the pool of cells. However, we observed that all cells that activated, regardless of the potency of their primary stimulus, achieved the same spectrum of effector-protein profiles, were able to release cytolytic granules, and reached this activated state using the same transcriptional pathway. Thus, we showed that the stimulation strength dictated how rapidly and uniformly the cells responded.
Results
Distinct transcriptional phases of early T cell activation. We first sought to characterize transcriptomic changes, by single-cell RNA sequencing (scRNA-seq), during the initial 6 h of activation of naive CD8 + T cells. We used the OT-I model (mice with transgenic expression of an MHC class I-restricted (ovalbumin-specific) TCR) to facilitate strict control of the timing of antigen encounter and the strength of the activating stimulus. Cells were isolated from OT-I mice deficient in the recombinase component Rag1, in which all peripheral CD8 + T cells recognize the ovalbumin peptide SIINFEKL (with asparagine at position 4 (N4)) presented by the MHC class I molecule H-2K b . Ex vivo CD8 + OT-I T cells were stimulated with pure peptide, to avoid contamination by RNA from APCs. By staining cells for surface protein expression before sorting them into lysis buffer for scRNA-seq, we simultaneously measured expression of four surface proteins and quantified genome-wide mRNA in the same cells. We assayed one protein, CD62L (L-selectin, encoded by Sell), that was downregulated with activation and three proteins, CD69, CD25 (encoded by Il2ra) and CD44, that were upregulated with activation.
We first profiled a time course of strong stimulation by sequencing the transcriptomes of individual OT-I CD8 + T cells after 0, 1, 3 or 6 h of activation with 1 µ M of the high-potency OT-I TCR cognate peptide N4 in the presence of the cytokine IL-2 ( Supplementary Fig. 1a ). 87% of cells passed quality-control filtering, which resulted in 44-64 cells per condition. Protein profiles revealed a rapid drop in the expression of CD62L, followed by sequential increases in the expression of CD69, CD25 and CD44 (Fig. 1a ). The examination of surface protein measurements and application of principal-component analysis to the mRNA data confirmed that despite the uniform activation stimulus, these cells were heterogeneous during the first 6 h of activation ( Fig. 1a,b ). Because of this diversity, simply grouping the cells by sampling time could not achieve the fine resolution needed to understand coordination of gene expression. Instead, we took advantage of the heterogeneity within each stimulation condition to order all cells by their progressively changing transcriptional profiles, and examined their progress in 'pseudotime' instead of real time. We used a diffusion pseudotime method 31 , which is a computational approach that finds the most direct path through the observed cell states on the basis of each cell's gene-expression profile. Fitting a diffusion pseudotime trajectory to the single-cell transcriptomic data, we created a fine-grained map of activation ( Fig. 1c and Supplementary Fig. 1b ).
The distribution along pseudotime of all cells from the various time points revealed three clusters of cells: resting cells, early activated cells and late activated cells ( Fig. 1d and Supplementary  Fig. 1c,d ). We performed a differential expression analysis to compare each activated cluster to the resting cells. Cells in the early stages of activation mainly increased their expression of genes encoding molecules involved in immunological and regulatory processes, whereas cells in the later stages of activation showed substantial upregulation of genes encoding molecules involved in metabolic and biosynthetic functions (Supplementary Table 1 ) that are critical for the effector differentiation of T cells 32, 33 . We then assessed genes expressed differentially in the early-activation cluster relative to their expression in both the resting cluster and late-activation cluster to identify transient early expression changes. Filtering for differentially expressed genes uniquely upregulated in early activation revealed enrichment for the number of genes encoding transcriptional regulators (enrichment P value, 1.8 × 10 −9 (hypergeometric test); Fig. 1e and Supplementary Fig. 1e ). In particular, genes encoding members of the early response NR4A family of orphan nuclear receptors, including Nur77 (Nr4a1), whose expression has been found to reflect TCR signaling activity 27, [34] [35] [36] , had their highest expression 1 h after activation ( Fig. 1f ). Additionally, genes encoding early growth-response factors (Egr1 and Egr2) and an AP-1 transcription factor subunit (Fosb) had similar expression patterns. Thus, we identified two distinct phases of the activation response.
Ligand potency controls the response rate of CD8 + T cells.
To determine how TCR stimulation strength might affect the early response noted above, we selected genes encoding two transcription factors characteristic of the early activation profile, Nr4a1 and Fosb, and assessed their expression by RNA flow cytometry while modulating TCR signaling strength. We stimulated cells with each of four peptides with previously characterized potency for stimulating the OT-I TCR 5, 37 : the cognate peptide SIINFEKL (N4); two variants of SIINFEKL with threonine at position 4 (SIITFEKL; T4) or glycine at position 4 (SIIGFEKL; G4) (potency: T4 > G4); and NP68 (ASNENMDAM), which does not bind the OT-I TCR. The same concentration (1 μ M) of each peptide was used, in order to saturate MHC occupancy 5, 11 . We cultured all cells 
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in an equivalent concentration of exogenous IL-2, as this cytokine is required for T cells to enter the cell cycle and proliferate. Given that IL-2 production varies with stimulation strength 33 , the addition of exogenous IL-2 enabled us to identify intrinsic changes in gene activation that were dependent solely on stimulation strength ( Supplementary Fig. 2a ,b). RNA hybridization was verified through analysis of the control gene Rpl39 ( Supplementary Fig. 2c,d ). The induction of Nr4a1 after 1 h was dependent on ligand strength, with ligands of higher potency driving the expression of Nr4a1 mRNA in a greater frequency of cells, in accordance with published studies 27, 34 (Fig. 2) . In cells stimulated with the most-potent ligand (N4), this frequency gradually decreased by 6 h, but in cells stimulated with the ligands of reduced potency (T4 and G4), the frequency of Nr4a1 + cells increased between 3 h and 6 h, suggestive of a delayed peak in the population response. Cells stimulated with the 'null peptide' NP68 upregulated Nr4a1 to a small extent after 1 h, suggestive of a combination of TCR-dependent effects and TCR-independent effects on induction. In contrast, Fosb was substantially upregulated at 1 h and rapidly returned to baseline by 3 h regardless of the peptide stimulus. These results indicated that within the immediate early burst of expression of genes encoding transcription factors, certain genes (exemplified by Nr4a1) responded mainly to TCR stimulation, while genes encoding another set of regulators (including Fosb) were probably driven by TCR-independent factors acting within the first hour of tissue culture. Our observation that ligands of lower potency resulted in lower immediate and delayed maximum expression of Nr4a1 suggested that the stimulation strength either altered the rate with which the cells embarked on a universal transcriptional activation pathway or controlled the utilization (or coordination) of separate activation pathways.
To test those possibilities, we performed scRNA-seq analysis of OT-I CD8 + T cells stimulated for 6 h with the same ligands used above. Protein profiling revealed that lowering the ligand potency increased heterogeneity in protein markers of early activation ( Fig. 3a and Supplementary Fig. 3a ). To determine whether ligand potency controlled transcriptional activation pathways, we combined data from cells stimulated for 6 h with each ligand and the time course of stimulation with the most potent ligand (N4). 93% of cells in this combined dataset passed quality-control filtering, which left 44-94 cells per condition. We excluded cells cultured for only 1 h to avoid the immediate TCR-independent effects described above. Using diffusion pseudotime analysis, we fitted a trajectory to the cells and found that it tracked activation status ( Fig. 3b ). We observed that cells stimulated with a ligand of medium potency (T4) or low potency (G4) did not follow an activation trajectory different from that of cells stimulated with the strongest ligand (N4). This indicated that all ligands promoted the same major transcriptional changes, including upregulation of biosynthetic and metabolic machinery. As noted for protein expression in the early hours of activation, lowering the ligand potency resulted in greater heterogeneity in progress along the activation trajectory ( Fig. 3c ). Cells activated by weaker ligands were not universally less activated, with a proportion of cells achieving activation comparable to that of cells stimulated with the ligand of highest potency. This indicated that stimulation strength controlled the probability that a cell would activate at any given moment, regulating the rate at which cells initiated transcriptional activation rather than the speed with which they progressed once activation was initiated. When measurements are summarized across the whole T cell population, a reduction in activation efficiency would appear as a reduction in the magnitude or fraction of cells responding, which have been described in numerous studies (exemplified by refs 15, 17, 18, 20, 21, 30 
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NATuRe ImmuNOlOgy genome-wide single-cell experiments were we able to distinguish the effect of response rate from differences in the frequency, speed of progression or phenotype of responding cells. Although we found the main activation trajectory was shared by cells stimulated by ligands of high or low potency, it remained possible that stimulation strength might cause subtle deviations. Extensive heterogeneity between cells makes it challenging to directly compare cells at the same activation stage after stimulation with different ligands. Even sorting cells on the basis of binary measures of activation status 14, 21, 30 might fail to account for heterogeneity within the activated populations. A benefit of our single-cell approach is that we were able to take advantage of the heterogeneity within stimulated populations to control for differences in activation state while comparing cells stimulated with various ligands. Surface expression of CD69 protein strongly correlated with transcriptomic activation status, demonstrating activation along our transcriptomic trajectory. CD69 expression could therefore be used as an independently measured feature to control for activation state in a differential RNA-expression analysis of cells treated with the various ligands ( Supplementary Fig. 3b ). This allowed us to answer the following question: given the activation state defined by CD69 expression, which genes were expressed differentially in cells in different stimulation conditions? Our analysis revealed only a small number of genes with differential expression in cells stimulated with different ligands (41 of 8,854 genes (0.46%) for G4 versus N4; and 30 of 8,854 genes (0.34%) for T4 versus N4), which confirmed that cells activated by different ligands shared a transcriptional response. Expression of a small subset of genes was directly affected by ligand potency ( Fig. 4a and Supplementary Tables 2 and 3 ). This included downregulated expression of chemokine-encoding genes, such as Xcl1, Ccl3 and Ccl4, particularly in cells stimulated with the low-potency ligand (G4), and upregulated expression of genes encoding proteins with roles in the presentation of antigen by MHC class I, such as Psmb8, Tapbp and B2m, particularly in cells stimulated with the ligand of medium potency (T4) (Fig.  4b,c and Supplementary Fig. 3c,d ). Although many genes, including the chemokine-encoding genes Ccl3 and Ccl4, have been previously observed to exhibit altered expression after stimulation with a weak ligand 15, 28 , here we demonstrated that this occurred for only a small subset of genes when we accounted for the activation status of the cells. Of particular importance, genes encoding molecules that direct the metabolic and biosynthetic programs of T cell activation did not show enrichment in our lists of differentially expressed genes relative to the 'background' set of all genes tested for differential expression; this suggested that all activated cells, regardless of ligand potency, were able to mount these energetic effector differentiation processes. Likewise, early transcription of Gzmb, which encodes the important cytolytic effector molecule granzyme B, did not differ significantly among stimulation conditions when we accounted for cellular activation status ( Supplementary Fig. 3e ). Our results indicated that while there were specific genes encoding molecules involved in leukocyte recruitment and endogenous peptide presentation whose expression depended on ligand strength, the overwhelming majority of genes expressed in early activation depended on activation status and not the potency of the stimulus.
Activated T cells achieve the same spectrum of effector phenotypes regardless of stimulation potency.
Having observed that regardless of the primary stimulus, activated T cells progressed along the same transcriptomic activation trajectory, we next investigated whether cells exhibited phenotypic differences associated with stimulation strength during the first 2 d of effector T cell differentiation. 
Residual Tapbp expression (log Residual B2m expression (log 2 )
Expression (log 2 fold) T4 vs N4
Fig. 4 | Accounting for activation status reveals minimal differential expression between cells activated with different ligands. a, Gene-expression
changes (log 2 fold) in cells stimulated with T4 versus those stimulated with N4 (T4 v N4), plotted against gene-expression changes in cells stimulated with G4 versus those stimulated with N4 (G4 v N4) (peptide stimuli and potency, Fig. 3 ), with each cell's activation status accounted for (as defined by surface expression of CD69 protein (log 10 values)), showing all 8,854 genes tested and those differentially expressed (false-discovery rate (FDR) < 0.05) for T4 versus N4, or G4 versus N4, or the intersection of T4 versus N4 and G4 versus N4 (Both) (key). Each symbol represents an individual gene. b,c, Residual expression (after expression of CD69 protein was accounted for) of selected chemokine-encoding genes (b) or genes encoding molecules associated with the presentation of antigen by MHC class I (c) in scRNA-seq data in cells stimulated with N4, T4 or G4 (horizontal axis), presented as box plots (as in Fig. 1f ). Each symbol represents an individual cell: n = 155 (N4), 91 (T4) or 94 (G4). *FDR < 0.05 (statistical test, Methods; statistical details, Supplementary Table 2 ).
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Because OT-I T cells can undergo extensive death when activated with soluble peptide for multiple days, we instead used peptidepulsed APCs to activate naive T cells for 2 d ( Supplementary Fig.  4a ). In this system, we observed negligible activation after 2 d of stimulation with the peptide of low potency (G4) (Fig. 5a ). This was in contrast to pure peptide stimulation with the same ligand, which, consistent with our observations of transcriptional activity at 6 h, drove full activation at 2 d ( Supplementary Fig. 4b ). We used autologous splenocytes depleted of T cells (the cells that remained after isolation of CD8 + T cells) as APCs. We pulsed the APCs with one of the four peptides used in our transcriptomic studies above or with Q4H7 peptide (SIIQFEHL), whose potency for stimulating OT-I T cells lies between that of the T4 peptide and G4 peptide 5 (mediumlow potency), and then stimulated ex vivo OT-I CD8 + T cells with those APCs in IL-2-supplemented medium. After 2 d of activation, the majority of T cells stimulated with the three strongest ligands (N4, T4 and Q4H7) were proliferating (Fig. 5a ). The proportion of cells in later division cycles and the total number of T cells were associated with stimulation strength (Fig. 5b ,c), in agreement with published observations suggesting an increased frequency of proliferating cells, shorter time to first division, or greater proliferation with stronger TCR-pMHC interactions 11, 12, 14, 16, 19, 21, 27 . We also noted that the most proliferative cells in each condition that stimulated proliferation had all undergone four divisions, which indicated that the few cells that began proliferating immediately after stimulation with weaker ligands were not slower to divide. Although it has been reported that stimulation strength affects the proportion of proliferating cells and the time to first division 22 , our results showed that weaker ligands did not cause a universal delay in proliferation but instead reduced the number of cells that activated immediately. Given these results, together with our results from the early-activation transcriptomic analysis, we concluded that ligand potency determines the rate with which an individual cell initiates activation and thus the heterogeneity of activation across the population.
Proliferation represents only one component of effector differentiation, and the expression of cytokines, cytotoxic mediators, and co-stimulatory or co-inhibitory receptors can control the phenotype of differentiated CTLs. In order to assess effector phenotypes without making prior assumptions about which proteins would be co-expressed, we used mass cytometry to simultaneously measure 19 surface and intracellular proteins related to the differentiation and effector function of T cells. After 2 d of stimulation with peptide-pulsed, T cell-depleted autologous splenocytes, we identified subpopulations of cells that changed in abundance 38 after stimulation with any ovalbumin peptide variant, relative to their abundance after stimulation with the 'null' peptide NP68.
The high-dimensional space defined by the 19 proteins measured was divided into phenotypic hyperspheres, and the abundance of cells from each condition was quantified within each hypersphere (Fig. 6a ). We identified phenotypic hyperspheres that differed significantly in abundance in any peptide-stimulation condition (Fig. 6b ). Examination of the protein-expression profiles that defined each phenotype revealed that similar to its proliferation profile, the least-potent ligand (G4) stimulated only a very small proportion of cells to transition from a CD44 lo CD62L hi naive phenotype to a CD44 hi CD62L lo effector phenotype ( Fig. 6c and Supplementary Fig. 5 ). In contrast, stronger ligands (N4, T4 and Q4H7) drove increased abundance of effector populations co-expressing many effectorassociated proteins, including the high-affinity IL-2 receptor subunit CD25, the cytotoxic mediator granzyme B, the co-inhibitory receptor CTLA-4 and the transcription factor T-bet, which promotes the effector differentiation of CD8 + T cells. This effector phenotype was present in all activated populations, regardless of the potency of the primary stimulus, and was validated for a subset of proteins by flow cytometry ( Supplementary Fig. 6a,b) . The expression of granzyme B in granzyme B-positive cells was marginally reduced for cells stimulated with the ligand of highest potency (N4) ( Supplementary Fig. 6c,d ), similar to published in vivo results 8 , but in contrast to that previous study, we did not observe a decrease in the frequency of granzyme B-positive cells with strong stimulation ( Supplementary Fig. 6b ). Of note, the cytokine IFN-γ was not expressed in all effector T cells after 2 d of stimulation and instead emerged in a small subset of cells (up to 20%), mainly after stimulation with ligands of medium or medium-low potency (T4 or Q4H7) ( Supplementary Fig. 6e-g) . Divergence of IFN-γ expression from other effector phenotypes has been noted in a published study 14 . However, its infrequent expression in effector cells and its disconnect from other effector protein phenotypes would suggest that IFN-γ is not representative of cytolytic effector-cell differentiation in this system.
We verified effector protein-expression phenotypes using wildtype splenocytes as APCs ( Supplementary Fig. 4c,d) . A small population of T cells stimulated with G4-pulsed wild-type APCs showed signs of activation. These activated cells acted similarly to those activated by other primary stimuli. Collectively, our phenotypic profiling would support a model in which ligand potency determines the rate with which cells embark on effector differentiation, but not the spectrum of effector phenotypes they can achieve.
All differentiated effector cells are cytolytic. The main effector function of CTLs is the targeted release of cytolytic granules after encounter with an antigen-presenting target cell. Cytolytic granules carry the lysosome-associated transmembrane protein LAMP1, which enables measurement of degranulation in individual cells via the quantity of LAMP1 that is transiently trafficked to the cell surface during antigen challenge. To determine how the TCR-pMHC affinity of a cell's primary stimulus might affect its degranulation after subsequent antigen encounter, we assayed the degranulation of CD8 + T cells activated with ligands of various potencies in response to target-cell challenge. We first assessed the ability of OT-I CD8 + T cells activated for 2 d with peptidepulsed APCs to respond to a second stimulus. Co-culture with target cells presenting the cognate peptide N4 drove an increase in LAMP1 on the cell surface in all effector-cell populations ( Fig. 7a ). Categorizing cells into subsets on the basis of division number or CD44 expression revealed that cells in the same activation state exhibited similar degranulation profiles after challenge, regardless of the primary stimulus (Fig. 7b,c) . Again, the use of wild-type APCs for primary stimulation yielded similar results ( Supplementary Fig. 7a-c) . After a week in culture, CTLs induced by ligands that drove substantial proliferation and effector differentiation (N4, T4 or Q4H7) still demonstrated considerable degranulation capacity (Fig. 7d) . Although we observed a slight dependence of degranulation on the potency of the primary stimulus ( Supplementary Fig. 7d,e ), this trend was absent in a target-cell-killing assay (Fig. 7e ). It has been demonstrated that 
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only proliferating cells are competent for cytolytic activity 14 . Our results demonstrated that the converse of this relationship is true by showing that all ligands tested that induced proliferation were able to produce cytolytically competent CTLs.
Discussion
Published studies have led to conflicting models of graded and threshold activation responses to ligand potency, including T cell response speed, response magnitude or proportion of responding cells 5, 11, 13, 14, [17] [18] [19] [20] [21] [22] 30 . We have resolved those various interpretations with an unbiased approach, revealing that ligand potency determined the rate with which the cells initiated transcriptional activation. Support for our model can be found in studies over the past decade that have looked at specific parts of the T cell response: the time to begin proliferation but not the proliferation speed has been found to be associated with signal strength 22 ; likewise, infection with low-potency Listeria monocytogenes results in curtailed population expansion of antigen-specific T cells but complete secondary responses after rechallenge 9 ; and ligand potency has been shown to determine the average time to initiate protein expression or proliferation, but the level of CD69 expression in activated cells is not affected 19, 21 . We have now demonstrated that those published results could all be attributed to signal strength-dependent modulation of the rate of response via shared activation machinery. Several in vivo studies have found that the strength of the primary stimulation can alter the CD8 + T cell-differentiation fate 12, 15, 23 . However, it has been difficult to tease apart the effect of ligand potency from that of antigen presentation, co-stimulatory context and other cells responding in vivo. The duration of T cell-APC interactions influences the magnitude or phenotype of T cell responses in various contexts 12, 36, 39, 40 . In addition, cells stimulated with ligands of reduced potency take longer, on average, to accumulate phosphorylated signaling mediators downstream of the TCR 19, 41 and might require more-sustained antigen presentation 14 . Furthermore, the length of time a T cell remains conjugated to an APC 8,12,42 , its motility 10,43 and its retention time in lymphoid organs 
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NATuRe ImmuNOlOgy in vivo 8, 9 are associated with ligand affinity, and affinity-dependent interaction time is also associated with the expression of co-inhibitory receptors 42 . Therefore, a T cell's environment will change with ligand affinity, which will probably affect its fate in vivo and not reflect its intrinsic capacity to respond. Finally, autocrine and paracrine availability of the cytokine IL-2 modulates the activation and proliferation of T cells 11, 14, 16, 24, 27, 28, 44 through activity of the kinase PI3K and cell-cycle regulator Myc 18, 26, 33, 45 , and weak stimulation can result in a level of IL-2 production insufficient to support a proliferative response 11, 16, 27, 33, 46 . However, IL-2 secreted by activated CD4 + or CD8 + T cells would probably be expressed in the lymphoid-tissue microenvironment in a physiological, polyclonal response, and cells stimulated by weak ligands can co-opt IL-2 from co-cultured cells stimulated by strong ligands 26 . Variation in these factors among experimental protocols have left the field unclear about whether cell-intrinsic ligand-strength-dependent T cell phenotypes exist. We have demonstrated that in a controlled cellular environment, all activated cells were able to achieve an effector phenotype via shared transcriptional machinery.
Published in vivo cytotoxicity studies have demonstrated reduced total killing by CTLs induced by low-potency ligands 8, 9, 12 . However, two reports have noted that early after activation, low-potency stimulation results in greater cytolytic capacity per cell than does high-potency stimulation 8, 9 . Strongly stimulated T cells are instead retained in the periarteriolar lymphoid sheaths of the spleen 9 or in the interfollicular regions of the lymph node in a manner dependent on the chemokine receptor CXCR3 8 , which reduces their availability for killing. In our data, RNA expression of Cxcr3 exhibited a non-significant trend toward downregulation in G4-stimulated cells after we accounted for activation status at 6 h (Supplementary Table 2 ), and genes encoding other chemokines and receptors were upregulated after high-potency stimulation, suggestive of additional potential mechanisms. In contrast, in an ex vivo killing assay, CTLs generated in vivo with high-potency ligands exhibited cytotoxicity comparable to that of their counterparts generated with low-potency ligands in the presence of exogenous IL-2 28 . In our controlled in vitro system, we found that all T cells that achieved an effector phenotype were cytolytically competent, which suggested that the large divergences observed in vivo were not intrinsic to the T cell response to TCR stimulation.
Ligand potency can affect TCR-induced signaling events upstream of transcription, including calcium flux 47, 48 , TCR-coreceptor interaction 41 , post-translational modification of signalingcascade components 5, 13, 17, 19, 29, 41 and translocation of transcription factors to the nucleus 13 . Such signaling mechanisms might drive the altered rate of transcription initiation that we have identified 49 . Future studies should consider what might cause specific cells to be the first to respond, particularly to low-potency stimulation. The expression of CD8 and SHP-1 (encoded by Ptpn6) as proteins and markers of metabolic activity are associated with response propensity in mature CTLs 50 and naive T cells 21 , respectively. Unfortunately, due to the destructive nature of the single-cell sequencing technologies, cells cannot be comprehensively profiled both before activation and after activation. Hypothesis-driven sorting experiments might be fruitful in identifying additional markers of poised cells, but ideally a genome-wide screening experiment would be needed to identify all contributing factors.
Our results have emphasized the importance of using singlecell approaches in the measurement of highly heterogeneous systems and in the identification of rate-based responses 46 . These methods have allowed us to examine the coordination of mRNA and protein phenotypes in individual cells to answer the following fundamental question in T cell biology: how does stimulation strength control the cell-intrinsic responses of naive T cells? We demonstrated that the main effect of ligand affinity was to control the rate with which naive T cells initiated activation, not to lower effector gene expression within activated cells or to drive the use of alternative transcriptional pathways. Additional environmental cues dependent on the nature of the antigen and other responding immune cell populations might adjust the ultimate phenotype of each clonal T cell response, but none of these characteristics are intrinsically determined by TCR signal strength. Indeed, the finding that heterogeneous, low-efficiency T cell-activation responses were able achieve full effector phenotype and function via the induction of genes encoding the same molecules that mediate synchronous responses to high-potency ligands would seem fundamental to the maintenance of flexibility and sensitivity in the immune system. Using the response rate to modulate clonal population size according to ligand strength makes use of common transcriptional machinery while allowing high-affinity clones to become the most prevalent and suppressing low-affinity clones with a near-zero activation rate. This model provides a mechanism by which peripheral CD8 + T cells can generate a full CTL response to a vast range of peptide antigens with a finite set of rearranged receptors and signaling components.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0160-9.
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Methods
Mice. Mice were bred and housed in the University of Cambridge CBS facility. The genotype of OT-I Rag1-deficient mice (OT-I Rag1 tm1Bal on a C57BL/6 background) was confirmed before study. The wild-type C57BL/6 N mouse line was obtained from the Wellcome Trust Sanger Institute Mouse Genetics Project (Sanger MGP).
Cell culture. The mouse lymphoblast EL4 cell line, originally from the Sir William Dunn School of Pathology Cell Bank, Oxford, was maintained in DMEM (Gibco) supplemented with 10% FBS (Biosera) and penicillin-streptomycin (Sigma) and tested negative for mycoplasma.
Dissected spleens from OT-I Rag1-deficient mice were homogenized through a 70-µ m filter. CD8 + T cells were isolated using the CD8a + T Cell Isolation Kit, mouse (Miltenyi). T cells were stimulated either by the addition of purified peptide or with pulsed APCs. T cell-depleted OT-I splenocytes (the positive fraction from CD8a + T cell separation) were used as APCs. Results were confirmed using wildtype splenocytes treated with RBC lysis buffer (eBioscience) as APCs. APCs were irradiated with ~3,000 rads and were pulsed for 2 h with peptide before washing and co-culture with isolated T cells. APCs were cultured with T cells at a ratio of 5:1 (OT-I APCs) or 2.5:1 (wild-type APCs). Where indicated, T cells were stained with the proliferation dye eFluor450 (eBioscience) according to the manufacturer's instructions before culture. Cells were cultured in medium composed of complete RPMI 1640 medium (Gibco), 10% FBS (Biosera), penicillin-streptomycin (Sigma), sodium pyruvate (Gibco), l-glutamine (Sigma), β -mercaptoethanol (Gibco) and, unless indicated otherwise, 20 ng/ml (≥ 100 U/ml) mouse IL-2 (Peprotech). The following peptides were used for stimulation at a concentration of 1 μ M unless otherwise indicated: SIINFEKL (N4), SIITFEKL (T4), SIIQFEHL (Q4H7), SIIGFEKL (G4) and ASNENMDAM (NP68) (Cambridge Bioscience). Although 1 μ M is a higher concentration than required for maximal activation of OT-I cells with pure N4 peptide 11, 17, 33 , we sought to keep this variable constant across all ligands, including G4, for which 1 μ M was required to maximize induction of CD69 expression 19 . We observed no inhibitory effect of excess N4 peptide on earlyactivation protein phenotypes ( Supplementary Fig. 1a ).
The rate of activation in response to the lowest potency ligand G4 differed between antigen-presentation systems with pure peptide and peptide-pulsed APCs. Under stimulation with pure peptide, G4 peptide was capable of activating transcription in approximately half of the cells after 6 h and by 2 d had activated proliferation of the whole population (Figs. 2 and 3 and Supplementary Fig. 4b) .
In contrast, G4-pulsed APCs induced negligible proliferation at 2 d ( Fig. 5 and Supplementary Fig. 4c ). These differences might have been due to concentration and chronicity of antigen presentation, such that changing the antigen-presenting system shifted the rate with which each ligand activated T cells but did not affect the ordering of these rates or the observation that all stimulation conditions capable of driving T cell activation used similar machinery. Our model in which ligand potency intrinsically determined relative activation rate is consistent with all of these observations.
Sorting for single-cell RNA-seq. Isolated naive OT-I T cells were stained with proliferation dye. 1 × 10 5 cells per well were stimulated with 1 µ M peptide in 200 µ l medium in 96-well round-bottomed plates. Cells were washed in PBS, blocked with FcR blocking antibody (clone 93, Biolegend) and stained with Zombie Aqua (Biolegend), anti-CD8a eVolve 655 (clone 53-6.7, eBioscience), anti-CD44 APC-eFluor780 (clone IM7, eBioscience), anti-CD44 APC-FIRE750 (clone IM7, Biolegend), anti-CD62L PE (clone MEL-14, eBioscience), anti-CD25 Alexa Fluor 488 (clone PC61.5, eBioscience), and anti-CD69 APC (clone H1.2F3, eBioscience). Anti-CD154 PE-Cy7 (clone MR1, Biolegend) and anti-CD71 PerCP-Cy5.5 (clone R17217, Biolegend) were also included in one experiment, but expression levels were largely invariant and therefore were not included in the analysis. Cells were sorted on a BD Influx (BD Biosciences), selecting live cells that expressed CD8 and that had not proliferated ( Supplementary Fig. 8a ). We did not see proliferation at the time points used for scRNA-seq. Expression of all surface proteins was recorded for each indexed cell. Two scRNA-seq experiments were performed: experiment 1 consisted of two 96-well plates of cells stimulated with the various peptides for 6 h; experiment 2 consisted of four 96-well plates of cells left unstimulated or stimulated for 6 h with N4, T4, G4 or NP68, for 3 h with N4, or for 1 h with N4. Within each experiment, cells from all conditions were included on each plate to avoid confounding of technical effects between plates. In each experiment, at least one well was left blank (without a cell) to monitor background levels of ambient RNA.
Single-cell RNA-seq. Sequencing library preparation was adapted from ref. 51 with the following modifications. Cells were sorted into 96-well plates holding 4 µ l of lysis buffer composed of 2.3 U SUPERase In RNase inhibitor (Thermo Fisher Scientific), 0.11% (v/v) Triton X-100 (Sigma), 12.5 mM DTT (Thermo Fisher Scientific) and 2.5 mM dNTP mix (Thermo Fisher Scientific). 1 µ l annealing mix containing ERCC RNA Spike-In Mix (Thermo Fisher Scientific; final dilution, 1 in 3 × 10 7 ) and 10 µ M oligo-dT30VN (Sigma) was added to each well before reverse transcription with SuperScript II (Invitrogen). cDNA amplification was performed with 23 PCR cycles, and the resulting PCR products were purified with Ampure XP Beads (Agencourt) at a volume ratio of 0.7:1 beads:DNA. Libraries were prepared using the Nextera XT DNA Sample Preparation Kit and indexes from the Nextera XT Index Kit v2 Set A and Nextera XT Index Kit v2 Set D (Illumina). Each plate of libraries was pooled, cleaned with Ampure XP beads, and quantified using KAPA Library Quantification Kit (Roche). Equimolar quantities of libraries from each plate were combined for sequencing. Single-end 50-bp sequencing was performed using a HiSeq 4000 (Illumina). Experiment 1 was sequenced in a single lane. Experiment 2 was sequenced on two lanes and the data were merged.
Single-cell RNA-seq alignment and QC. Sequencing reads were aligned to the mm10 genome and ERCC transcripts using subread v 1.5.1 52 in RNA-seq mode with unique mapping. The number of reads mapping to exonic regions of each gene were counted using featureCounts 53 (implemented in Rsubread v1.20.6) with a minimum quality score threshold of 10 and annotation from Ensembl GRCm38 version 82. Each sequencing run was aligned and counted separately. For cells sequenced twice, counts were summed.
Data were organized using the scran and scater Bioconductor packages 54, 55 . Cells were filtered as follows for quality control: exclusion of samples where flow cytometry had recorded multiple sorted cells; exclusion of cells with low numbers of mapped reads or genes detected (threshold defined as 3 median absolute deviations (MADs) below the median log 10 value); exclusion of cells with a high frequency of reads mapped to ERCC spike-in controls or mitochondrial genes (3 MADs above the median value); exclusion of cells with high or low ratio of ERCC spike-in controls to endogenous genes (3 MADs from the median difference of log 2 values). All filters were applied on the whole dataset, and the union of excluded cells was removed. After filtration, experiment 1 retained 184 of 191 sorted cells, and experiment 2 retained 344 of 376 sorted cells. Blank wells were automatically excluded through the filtering steps.
Single-cell RNA-seq analysis. Within each sequencing run, genes were filtered for those detected in at least 5% of cells and those with a mean count of at least 1. Data was normalized using size factors calculated from ERCC spike-in controls to account for variation in total mRNA 56 . Log 2 transformation was performed on the normalized expression values, after the addition of a pseudocount of 1. Batch effects between 96-well plates were removed by application of ComBat 57 in the sva Bioconductor package to the log-expression values, including stimulation condition as a preserved covariate. For analyses of the combined data, genes were required to meet filtering criteria in both sequencing datasets before following the same normalization and batch-correction procedure on the combined data.
Non-branching diffusion pseudotime analysis was performed using a modified version of the dpt package 31 to create a diffusion map of the cells and find the most probable activation trajectory. Analysis was performed using the first 50 scaled principal components and a Euclidean distance metric. The starting point of the fit trajectory, at pseudotime 0, is known as the 'root cell' . We required that the root cell be from the unstimulated condition. In the situation in which a root cell was not automatically identified from that condition, pseudotime was fit to only the subset of cells from the most-and least-stimulated conditions to find a root cell, and this cell was subsequently used as root in the full analysis. Clustering along pseudotime was performed using the classInt package for 1-dimensional class interval selection using the 'jenks' method. To identify the most biologically variable genes among unstimulated cells, we first used the trendVar function of the scran Bioconductor package 54 to fit a parametric curve followed by loess smoothing (span = 0.95) to the variance versus the mean log expression of the spike-in transcripts. Biological variances of endogenous genes were then obtained by decomposition of the variance using the decomposeVar function. Heat maps were generated using the pheatmap R package.
Differential expression analyses were performed by GLM in edgeR 58, 59 with a likelihood ratio test, using effective library sizes derived from the spike-in size factors and blocking on the plate of origin for each cell. We performed differential expression analysis between stimuli of varying affinities while controlling for activation status by additionally blocking on a spline basis matrix (four degrees of freedom) for CD69 protein expression (log 10 values) within each sequencing run to allow for nonlinear trends in protein expression.
Gene-ontology category enrichment of differentially expressed genes (FDR < 0.05) was performed using the goana function from the limma Bioconductor package. The significance threshold for enrichment was set at FDR < 0.05 (Benjamini Hochberg procedure). Enrichment for genes encoding transcriptional regulatory molecules was calculated by the hypergeometric test of enrichment for transcription factor-encoding genes (annotated in TcoF-DB v2 60 ) within genes significantly upregulated (log-FC > 0, FDR < 0.05) in the earlyactivation cluster relative to their expression in the resting and late-activation clusters. The 'gene universe' for this analysis consisted of all genes tested for differential expression.
RNA flow cytometry.
Control genes for RNA flow cytometry were determined from scRNA-seq data. We began with the sequencing run containing both the time course for stimulation with the high-potency ligand (N4) and that for the stimulations with ligands of reduced potency for 6 h (experiment 2). Genes were filtered for those detected in at least 80% of cells in each condition. Gene variances were calculated from the spike-in-normalized, log-transformed reads 1 nature research | reporting summary A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
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Data collection
Single-cell RNA-sequencing data were collected on an Illumina HiSeq4000 sequencer using Hiseq Control Software (version HD 3.4.0.38). Mass cytometry data were collected on a Fluidigm Helios CyTOF System using Fluidigm CyTOF Software (v6.5.358). Flow cytometry data were collected using BD FACSDiva software (v8). Killing assay colorimetric data were collected using SoftmaxPro 5.4.1 software.
Data analysis
scRNA-seq data was aligned using subread v 1.5.1 and reads counted using featureCounts implemented in Rsubread v1.20.6.
scRNA-seq and mass cytometry data analyses were performed in R v3.4.3 using the following packages: scater_1.6.3 scran_1.6.9 SingleCellExperiment_1.0.0 dpt_0.6.0 (Haghverdi. 2016. Nat Methods, 13:845.) destiny_2.6.2 sva_3.26.0 edgeR_3.20.9 limma_3.34.9 Rtsne_0.13 pheatmap_1.0.8 classInt_0.1-24 cydar_1.2.1
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ncdfFlow_2.24.0 flowCore_1.44.2 Scripts for these analyses will be made available at https://github.com/MarioniLab/SingleCellAPL2018.
Flow cytometry experiments were analyzed using FlowJo (v9) and Graphpad Prism (v7).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability scRNA-seq data are available in the ArrayExpress repository, accession number E-MTAB-6051. Mass cytometry data are available in the Cytobank repository, accession number 66456. The remaining data that support the findings of this study are available from the corresponding authors upon request.
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Sample size
No sample size calculation was performed prior to data collection. Our experiments examined the distributions of cell through single-cell analyses. The sample sizes used provided adequate information about these distributions as demonstrated through biological reproducibility.
Data exclusions Cells were only excluded from single-cell sequencing and mass cytometry experiments if they failed quality control metrics designed to detect poor quality cells. Filtering was performed before analyses. Samples were not excluded from flow cytometry analyses unless a severe anomaly was detected in the cell size gate (which occurred in one sample).
Replication
Findings were reproduced through biological replicates and complementary measurements using second technologies or biological systems. The number of independent experiments are indicated for each figure in the manuscript. Experiments were only deemed failures and thereby excluded if data was not generated or if technical issues made data unreliable. The latter was the case for one protein phenotyping experiment in which a flow cytometry laser failed.
Randomization Experimental groups consisted of cells treated under different conditions. In all experiments, cells for each condition were taken from a homogeneous pool. For single-cell RNA sequencing, cells from all tested conditions were represented on every plate to avoid confounding from technical effects.
Blinding
For single-cell RNA sequencing, cells from each condition were sorted into different positions on each plate to avoid confounding from technical effects. For mass cytometry experiments, cells from each condition were barcoded and all conditions pooled for staining and analysis to avoid confounding technical effects. All analyses were performed without considering the identity of sample groups except where a control biological group was necessarily used as reference as described in the methods.
Materials & experimental systems
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Methodology
Sample preparation T cells isolated from the spleens of OT-I Rag1-deficient mice were stained immediately or cultured for the indicated times before staining. Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
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